Can Serum Testosterone Be Used As a Marker of Overall Health?

Overview

Journal Rev Urol

Date 2016 Feb 4

PMID 26839520

Citations 2

Authors

Michael A Mederos

Aaron M Bernie

Jason M Scovell

Ranjith Ramasamy

Affiliations

Soon will be listed here.

Abstract

Low serum testosterone has been associated with obesity, type 2 diabetes, metabolic syndrome, and atherosclerosis. Individuals with these comorbidities are at increased risk of premature death and other adverse health effects. Clinical data portend low testosterone as a risk factor for developing these conditions which are supported by the hypogonadal-obesity-adipocytokine hypothesis. The authors support comprehensive evaluation for these comorbid conditions in men found to have low serum testosterone.

Citing Articles

Genetic determinants of plasma testosterone in male blood donors are associated with altered red blood cell characteristics and survival in cold storage and after transfusion.

Fang F, Roubinian N, Bean S, Kemmler C, Page G, Kanias T Transfus Apher Sci. 2024; 63(6):104017.

PMID: 39427552 PMC: 11641673. DOI: 10.1016/j.transci.2024.104017.

Andrology: Ibuprofen and hypogonadism - bench to bedside to misinterpreted hype?.

Nangia A, Jensen D Nat Rev Urol. 2018; 15(5):268-269.

PMID: 29508852 DOI: 10.1038/nrurol.2018.26.

References

Flegal K, Kit B, Orpana H, Graubard B . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82. PMC: 4855514. DOI: 10.1001/jama.2012.113905. View

Khaw K, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R . Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation. 2007; 116(23):2694-701. DOI: 10.1161/CIRCULATIONAHA.107.719005. View

Travison T, Araujo A, Kupelian V, ODonnell A, McKinlay J . The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2006; 92(2):549-55. DOI: 10.1210/jc.2006-1859. View

Yeap B, Chubb S, Hyde Z, Jamrozik K, Hankey G, Flicker L . Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. Eur J Endocrinol. 2009; 161(4):591-8. DOI: 10.1530/EJE-09-0348. View

Alkamel A, Shafiee A, Jalali A, Boroumand M, Nozari Y . The association between premature coronary artery disease and level of testosterone in young adult males. Arch Iran Med. 2014; 17(8):545-50. DOI: 014178/AIM.005. View

Laaksonen D, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen T, Valkonen V . Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004; 27(5):1036-41. DOI: 10.2337/diacare.27.5.1036. View

Kupelian V, Page S, Araujo A, Travison T, Bremner W, McKinlay J . Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006; 91(3):843-50. DOI: 10.1210/jc.2005-1326. View

Wellen K, Hotamisligil G . Inflammation, stress, and diabetes. J Clin Invest. 2005; 115(5):1111-9. PMC: 1087185. DOI: 10.1172/JCI25102. View

Nakamura K, Fuster J, Walsh K . Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2013; 63(4):250-9. PMC: 3989503. DOI: 10.1016/j.jjcc.2013.11.006. View

10.

Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F . Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2010; 8(1):272-83. DOI: 10.1111/j.1743-6109.2010.01991.x. View

11.

Laaksonen D, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen T, Salonen R . Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003; 149(6):601-8. DOI: 10.1530/eje.0.1490601. View

12.

Dhindsa S, Miller M, McWhirter C, Mager D, Ghanim H, Chaudhuri A . Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010; 33(6):1186-92. PMC: 2875421. DOI: 10.2337/dc09-1649. View

13.

Ungefroren H, Gieseler F, Fliedner S, Lehnert H . Obesity and cancer. Horm Mol Biol Clin Investig. 2015; 21(1):5-15. DOI: 10.1515/hmbci-2014-0046. View

14.

Yassin D, Doros G, Hammerer P, Yassin A . Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med. 2014; 11(6):1567-76. DOI: 10.1111/jsm.12523. View

15.

Fui M, Dupuis P, Grossmann M . Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014; 16(2):223-31. PMC: 3955331. DOI: 10.4103/1008-682X.122365. View

16.

Allan C, McLachlan R . Androgens and obesity. Curr Opin Endocrinol Diabetes Obes. 2010; 17(3):224-32. DOI: 10.1097/MED.0b013e3283398ee2. View

17.

Kapoor D, Malkin C, Channer K, Jones T . Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf). 2005; 63(3):239-50. DOI: 10.1111/j.1365-2265.2005.02299.x. View

18.

Cao J, Chen T, Hao W, Li J, Liu L, Zhu B . Correlation between sex hormone levels and obesity in the elderly male. Aging Male. 2012; 15(2):85-9. DOI: 10.3109/13685538.2012.666585. View

19.

Cunningham G . Testosterone and metabolic syndrome. Asian J Androl. 2015; 17(2):192-6. PMC: 4650473. DOI: 10.4103/1008-682X.148068. View

20.

Rubinow K, Snyder C, Amory J, Hoofnagle A, Page S . Acute testosterone deprivation reduces insulin sensitivity in men. Clin Endocrinol (Oxf). 2011; 76(2):281-8. PMC: 3224202. DOI: 10.1111/j.1365-2265.2011.04189.x. View